SAN FRANCISCO—March 3, 2010—With obesity and obesity-related diseases epidemic in the developed world, a clear understanding of how metabolism is regulated is crucial. One of the key metabolic pathways involves the oxidation of fat.
Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.
Julie Langelier, Science Writer and Public Relations Specialist
Direct line: 415.734.5000
Megan McDevitt, Vice President of Communications
Direct line: 415.734.2019
SAN FRANCISCO, CA—February 18, 2010—Lennart Mucke, MD, Director of the Gladstone Institute of Neurological Disease (GIND), has been named a recipient of the American Academy of Neurology's prestigious Potamkin Prize.
WASHINGTON—February 10, 2010—Robert W. Mahley, MD, PhD, president of The J. David Gladstone Institutes, will receive Research!America's 2010 Builders of Science Award.
SAN FRANCISCO, CA—February 8, 2010—The J. David Gladstone Institutes has announced the completion of its first fundraising campaign. The independent biomedical research organization, located at Mission Bay, said it had exceeded its goal of $35 million, despite tough economic times.
SAN FRANCISCO, CA—February 3, 2010—Although obesity is a risk factor for diabetes and coronary heart disease worldwide, only some obese individuals go on to develop these metabolic complications, while others are relatively protected.
SAN FRANCISCO, CA—Shinya Yamanaka, MD, PhD, of the Gladstone Institute of Cardiovascular Disease (GICD) was awarded the 2010 March of Dimes Prize in Developmental Biology.
SAN FRANCISCO, CA—January 13, 2010—Scientists at the Gladstone Institute of Neurological Disease (GIND) have identified the reason a key protein plays a major role in two neurodegenerative diseases.
SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have discovered a new agent that might inhibit the infectivity of HIV. The agent, surfen, impairs the action of a factor in semen that greatly enhances the viral infection.
SAN FRANCISCO, CA—Stimulating the growth of new neurons to replace those lost in Alzheimer's disease (AD) is an intriguing therapeutic possibility. But will the factors that cause AD allow the new neurons to thrive and function normally?
SAN FRANCISCO, CA—November 9, 2009—The Gladstone Institutes today announced that it has hired Bruce Spaulding, who recently retired as UCSF'S senior vice chancellor of advancement and planning as its new chief of strategic planning, effective December 14th.